Bovine Respiratory Disease Treatment Market - By Drug Type (Antibiotics, Vaccines, NSAIDs, Immunomodulators and Others), By Disease Type (Upper Respiratory Tract Infections, Pneumonia, and Diphtheria), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Private Veterinary Pharmacies, Veterinary Research Institutes, and Online Pharmacies), and By Region - Global Opportunity Analysis and Industry Forecast, 2020 – 2030

Bovine Respiratory Disease Treatment Market size valued USD 449 million in 2020 is expected to reach USD 3279.78 million growing with a CAGR of 22 % over the forecast period.Bovine respiratory disease (BRD) is the most common and costly disease attacking beef cattle in the world. It is a complex, bacterial infection that causes pneumonia in calves which can be fatal. Symptoms including such as high fever, nasal discharge, rapid and shallow breathing, coughing, diminished, or no appetite. It is not a contagious disease. For the treatment of the BRD, vaccines are available. The most commonly used vaccine for veterinary respiratory diseases is antimicrobial agents, Non-steroidal anti-inflammatory drugs (NSAIDs), mucolytic agents. Oral rehydration, fluids, Bronchodilators, and immunomodulators.

Market Segmentation:

The global bovine respiratory disease treatment market is classified on the basis of drug type into Antibiotics, vaccines, NSAIDs, immunomodulators, and others. On the basis of the disease, the market is segmented into upper respiratory tract infections, pneumonia, and diphtheria. By distribution channel the market is divided into veterinary hospitals, veterinary clinics, private veterinary pharmacies, veterinary research institutes, and online pharmacies. And by region the bovine respiratory disease treatment market is segmented into North America, Europe, Asia-Pacific, and RoW.

Market Dynamics and Factors:

According to the study, the increasing consumption of beef and the rising population are the major factors that are driving the bovine respiratory disease treatment market. The increase in beef consumption is due to the rising population and increasing disposable income, across the globe. Bovine Respiratory Disease (BRD) has a negative impact on the dairy and beef industries, due to calf mortality, treatment expenses, and additional labor costs. Additionally, BRD adversely affects the reproductive performance, growth, and lifespan of cattle. Consequently, there is a huge necessity for bovine respiratory disease treatment market. Moreover, to meet, the increasing demand for beef, most of the countries in the world are expanding the production of cattle meat. The rising demand for beef, increased production, leads to the growing importance of bovine respiratory disease treatment market. There are certain difficulties that are associated with the diagnosis of the BRD. Animals suffering from BRD often show signs of depression, weight loss, cough, nasal discharge, high fever, increased respiratory rate, and abnormal pulmonary sound on auscultation. The presumptive diagnosis after a physical examination is difficult, owing to the similarities of clinical signs and variation of possible bacteria. Hence, the complex diagnostic procedure is controlled the bovine respiratory disease treatment market growth.

Geographic Analysis:

Among the regions, North America is dominated the market in 2019 by contributing the largest bovine respiratory disease treatment market share in terms of revenue, due to increasing awareness about diseases and its treatment, high consumption of beef, increasing production and export beef, and the presence of companies available for manufacturing vaccines for bovine respiratory diseases. Asia Pacific is anticipated to grow at a higher CAGR Around 8.2% during the forecast period. Because of the growing population in India and China.

Competitive Scenario:

The market key players operating in the bovine respiratory disease treatment industry are Bayer Corporation, Boehringer Ingelheim GmbH, Bimeda Animal Health, Elanco, Vetoquinol S.A., Merck & Co Inc., Zoetis Inc., Novartis Animal Health, Vibrac S.A., Ceva Sante Animale, and Bimeda Animal Health.

Bovine Respiratory Disease Treatment Market Report Scope